Drug Type CAR-T |
Synonyms EphA3 Targeted CAR-T (Mayo Clinic) |
Target |
Mechanism EphA3 inhibitors(Ephrin type-A receptor 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Preclinical | US | 07 May 2024 |